Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

Ítems similars

• Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
  per: Sharma, A. K., et al.
  Publicat: (1994)
• Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
  per: Gee, Julia MW, et al.
  Publicat: (2004)
• Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
  per: Burmi, RS, et al.
  Publicat: (2006)
• New insights into acquired endocrine resistance of breast cancer
  per: Fan, Ping, et al.
  Publicat: (2019)
• The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.
  per: Johnston, S. R., et al.
  Publicat: (1997)